Chitkara University | India
Dr. Rajwinder Kaur is a distinguished pharmaceutical chemist, academic leader, and researcher with over 16 years of experience in teaching, research, and academic administration. Currently serving as Assistant Dean (PharmD Program) and Professor, she has made significant contributions to pharmaceutical chemistry, drug design, and therapeutic innovation. Her research focuses on computer-aided drug design (CADD), the discovery of novel chemical entities as adenosine receptor ligands, and the development of therapeutic agents for asthma, inflammation, Alzheimer’s disease, depression, and neuroprotection. She has also advanced the scientific understanding of natural products by identifying phytoconstituents with antidepressant, neuroprotective, anti-inflammatory, and antifungal potential. As Principal Investigator, she successfully completed a prestigious DST Women Scientist (WOS-A) project on thiophene derivatives. Dr. Kaur’s scholarly contributions include impactful publications in high-ranking international journals such as Chemistry Africa, Frontiers in Pharmacology, Journal of Biomolecular Structure and Dynamics, Pharmaceutics, Pharmaceuticals, Polymers, CNS Medicinal Chemistry, and more. Her work spans synthetic chemistry, molecular modeling, nanocarrier-based drug delivery systems, biomarker discovery, and MAO-A inhibitor development. She has authored multiple books with NOVA Science Publishers, highlighting her multidisciplinary expertise. With a strong innovation portfolio, she holds several patents related to thiophene derivatives, novel drug-delivery devices, chemical catalyzers, and therapeutic compounds. Her excellence has been recognized through numerous honors, including the Best Faculty Award, Young Scientist Awards, Gold Medals, and several national accolades. She is also an active member of globally recognized professional bodies such as the ACS, HKCBEES, and APTI. Through her impactful research, innovation, mentoring, and leadership, Dr. Rajwinder Kaur continues to shape the future of pharmaceutical sciences and stands as an exemplary researcher and educator.
Featured Publications
1. Choudhary, D., Kaur, R., Rani, N., Kumar, B., Singh, T. G., Chandrasekaran, B., Rawat, R., & Eyupoglu, V. (2025). Insights into in silico analysis to explore the multitarget antidepressant role of Camellia sinensis. Journal of Biomolecular Structure and Dynamics, 1–13.
2. Rani, A., Kaur, R., Aldahish, A., Vasudevan, R., Balaji, P., Dora, C. P., Chandrasekaran, B., Singh, T. G., & Sharma, R. (2025). Nanostructured lipid carriers (NLC)-based topical formulation of hesperidin for effective treatment of psoriasis. Pharmaceutics, 17(4), 478.
3. Choudhary, D., Kumar, B., Chandrasekaran, B., Singh, T. G., Kaur, R., Aldahish, A., Vasudevan, R., & Balaji, P. (2025). Microwave-assisted synthesis of morpholine-based chalcones as reversible MAO-A inhibitors in the management of mental depression. Pharmaceuticals, 18(3), 309.
4. Singh, J. K., Kaur, S., Chandrasekaran, B., Kaur, G., Saini, B., Kaur, R., Silakari, P., Kaur, N., & Bassi, P. (2024). A QbD-navigated approach to the development and evaluation of etodolac–phospholipid complex containing polymeric films for improved anti-inflammatory effect. Polymers, 16(17), 2517.
5. Singh, R., Rani, N., Kaur, R., Chahal, G., Kumar, P., & Kaur, G. (2024). Exploring the therapeutic potential of alkaloids in Alzheimer’s disease management. Central Nervous System Agents in Medicinal Chemistry, 24(2), 206–218.